The Pharmaceutical Society of Australia (PSA) is calling on existing community pharmacy wholesale supply chain arrangements to facilitate delivery of the COVID-19 vaccine stock into local chemists.
The Federal Government announced COVID-19 vaccines would be made available to Australians next year free of charge if trials are successful and they are proven to be safe and effective, meeting all necessary regulatory requirements.
The Pharmaceutical Society of Australia (PSA) National President Associate Professor Chris Freeman said administering a COVID-19 vaccine will be the primary way out of this pandemic and we will need all hands on deck to ensure that there is wide and comprehensive update of the vaccine.
PSA has written to state and territory governments asking that any required legislative amendments are made now in preparation for when the vaccine becomes available.
“We strongly recommend that the existing community pharmacy wholesale supply chain arrangements to facilitate delivery of the vaccine stock into community pharmacies,” Chris said.
“A proactive approach to legislative amendments now means that when the vaccine is available all jurisdictions around Australia will be ready to go, with the entire available health care workforce including pharmacists able to undertake a large-scale vaccination program.”
Some state and territory governments have already passed legislation that will allow pharmacists to administer the COVID-19 vaccine if and when it becomes available Chris said pharmacists are more than capable and qualified to provide this service.
As part of the recently signed seventh community pharmacy agreement the Federal Government committed to supporting for harmonization of pharmacist vaccines across all Australian jurisdictions.
Associate Professor Freeman said recently we have seen pharmacists with improved vaccination scope provided to the community and the delivery of the COVID-19 vaccine should be viewed no differently.
“The large scale rollout of this vaccine can only be achieved by also utilising pharmacist immunisers conveniently located in the community across Australia,” he said.
“This will be particularly critical in rural and remote areas where there may be a limited number of GPs.”